197 related articles for article (PubMed ID: 36142509)
1. Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model.
Kim J; Kang S; Chang KA
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142509
[TBL] [Abstract][Full Text] [Related]
2. Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model.
Kang S; Ha S; Park H; Nam E; Suh WH; Suh YH; Chang KA
Front Behav Neurosci; 2018; 12():273. PubMed ID: 30483077
[TBL] [Abstract][Full Text] [Related]
3. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
5. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
6. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
[TBL] [Abstract][Full Text] [Related]
7. Dehydroevodiamine•HCl Protects Against Memory Impairment and Cerebral Amyloid-β Production in Tg2576 Mice by Acting as a β-Secretase Inhibitor.
Shin KY; Noh SJ; Park CH; Jeong YH; Chang KA; Yoo J; Kim HJ; Ha S; Kim HS; Park HJ; Lee JH; Moon C; Suh YH
CNS Neurol Disord Drug Targets; 2016; 15(8):935-944. PubMed ID: 27577574
[TBL] [Abstract][Full Text] [Related]
8. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
9. Depressive-like Behaviors Induced by mGluR5 Reduction in 6xTg in Mouse Model of Alzheimer's Disease.
Kim Y; Kim J; Kang S; Chang KA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629191
[TBL] [Abstract][Full Text] [Related]
10. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
[TBL] [Abstract][Full Text] [Related]
11. Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.
DaRocha-Souto B; Coma M; Pérez-Nievas BG; Scotton TC; Siao M; Sánchez-Ferrer P; Hashimoto T; Fan Z; Hudry E; Barroeta I; Serenó L; Rodríguez M; Sánchez MB; Hyman BT; Gómez-Isla T
Neurobiol Dis; 2012 Jan; 45(1):425-37. PubMed ID: 21945540
[TBL] [Abstract][Full Text] [Related]
12. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
[TBL] [Abstract][Full Text] [Related]
13. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells.
Onder S; Biberoglu K; Yuksel M; Tacal O
Chem Biol Interact; 2022 Oct; 366():110126. PubMed ID: 36027949
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease.
Pan K; Chen S; Wang Y; Yao W; Gao X
Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312
[TBL] [Abstract][Full Text] [Related]
15. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
[TBL] [Abstract][Full Text] [Related]
16. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.
Hurtado DE; Molina-Porcel L; Carroll JC; Macdonald C; Aboagye AK; Trojanowski JQ; Lee VM
J Neurosci; 2012 May; 32(21):7392-402. PubMed ID: 22623685
[TBL] [Abstract][Full Text] [Related]
17. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
[TBL] [Abstract][Full Text] [Related]
18. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
19. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease.
Park H; Lee YB; Chang KA
Int J Biol Sci; 2022; 18(5):2220-2234. PubMed ID: 35342350
[No Abstract] [Full Text] [Related]
20. A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.
Modi KK; Jana A; Ghosh S; Watson R; Pahan K
PLoS One; 2014; 9(8):e103606. PubMed ID: 25089827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
